PCSAProcessa Pharmaceuticals, Inc.

PCSA Stock Price, Valuation & Chart | Processa Pharmaceuticals, Inc.

Compare

$2.100+0.05 (+2.44%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology PCSA intrinsic value PCSA calculated fair value vs price

Overview Financials Dividends Ratios

PCSA Historical price chart

PCSA Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization5.81M

PE Ratio-0.08

EPS-27.79

Trading Volume12.12K

Today's High/Low2.18/2.05

Dividend Yield0.00

52 Week High/Low14.25/1.67

Shares Outstanding2.77M

PCSA Financial Statement

PCSA Analyst ratings

PCSA Analysis & performance metrics

PCSA Company profile

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs…

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosis lipoidica, a chronic disfiguring…

PCSA Management team

Name

Position

Steven Cha M.D.

Senior Vice President of Clinical Research

George K. Ng Esq., J.D.CEO

Chief Executive Officer & Director

David Young Ph.D., Pharm.D.CTO

Co-Founder, President of Research and Development & Director

Russell L. Skibsted M.B.A.CFO

Chief Financial Officer

Sian E. Bigora Ph.D., Pharm.D.

Co-Founder and Chief Development & Regulatory Officer

Patrick Lin

Co-Founder, Chief Business & Strategy Officer

Wendy J. Guy

Co-Founder, Chief Administrative Officer & Corporate Secretary

Name

Position

Steven Cha M.D.

Senior Vice President of Clinical Research

George K. Ng Esq., J.D.CEO

Chief Executive Officer & Director

David Young Ph.D., Pharm.D.CTO

Co-Founder, President of Research and Development & Director

Russell L. Skibsted M.B.A.CFO

Chief Financial Officer

Sian E. Bigora Ph.D., Pharm.D.

Co-Founder and Chief Development & Regulatory Officer

Patrick Lin

Co-Founder, Chief Business & Strategy Officer

Wendy J. Guy

Co-Founder, Chief Administrative Officer & Corporate Secretary

Management Team

Steven Cha M.D.

Senior Vice President of Clinical Research

George K. Ng Esq., J.D.CEO

Chief Executive Officer & Director

David Young Ph.D., Pharm.D.CTO

Co-Founder, President of Research and Development & Director

Russell L. Skibsted M.B.A.CFO

Chief Financial Officer

Sian E. Bigora Ph.D., Pharm.D.

Co-Founder and Chief Development & Regulatory Officer

Patrick Lin

Co-Founder, Chief Business & Strategy Officer

Wendy J. Guy

Co-Founder, Chief Administrative Officer & Corporate Secretary

Management

Steven Cha M.D.

Senior Vice President of Clinical Research

George K. Ng Esq., J.D.CEO

Chief Executive Officer & Director

David Young Ph.D., Pharm.D.CTO

Co-Founder, President of Research and Development & Director

Russell L. Skibsted M.B.A.CFO

Chief Financial Officer

Sian E. Bigora Ph.D., Pharm.D.

Co-Founder and Chief Development & Regulatory Officer

Patrick Lin

Co-Founder, Chief Business & Strategy Officer

Wendy J. Guy

Co-Founder, Chief Administrative Officer & Corporate Secretary

Total 7 executives

PCSA Frequently asked questions

What is Processa Pharmaceuticals, Inc. (PCSA) Stock Price?

Current stock price of Processa Pharmaceuticals, Inc. (PCSA) stock is $2.100. The stock price is +2.44% higher in the session. The intraday range can be seen from this page. Volume of Processa Pharmaceuticals, Inc. (PCSA) stock is 12.12K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Processa Pharmaceuticals, Inc. (PCSA) stock price going up or down today?

The stock price of Processa Pharmaceuticals, Inc. (PCSA) can change with earnings, company news, and overall market sentiment. Processa Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Processa Pharmaceuticals, Inc. stock expensive at its current price?

Whether Processa Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PCSA on this page is -0.08. EPS on this page is -27.79. Compare those figures with peers and growth expectations before deciding if the current Processa Pharmaceuticals, Inc. price is justified.

How has the stock price of Processa Pharmaceuticals, Inc. (PCSA) performed historically?

Historical performance for Processa Pharmaceuticals, Inc. (PCSA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PCSA reacted to past earnings and market events.

Should I buy Processa Pharmaceuticals, Inc. (PCSA) stock, at this price?

Buying Processa Pharmaceuticals, Inc. (PCSA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.